Armata Pharmaceuticals (ARMP) Tax Provisions (2015 - 2017)
Armata Pharmaceuticals (ARMP) posted Tax Provisions of -$1.3 million for Q2 2017, down 1683.56% sequentially from -$73000.0 in Q4 2015.
Armata Pharmaceuticals (ARMP) Tax Provisions (2015 - 2017) Analysis & Trends
Armata Pharmaceuticals has reported Tax Provisions for 2 years, with the latest figure at -$1.3 million in Q2 2017.
- Quarterly Tax Provisions changed N/A year-over-year to -$1.3 million in Q2 2017, while the trailing twelve-month figure through Dec 2017 was -$1.4 million (changed N/A YoY) and the FY2018 annual result came in at -$328000.0, up 74.81% from the prior year.
- Tax Provisions eased to -$1.3 million in Q2 2017 per ARMP's latest filing, from -$73000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at -$73000.0 in Q4 2015 and troughed at -$1.3 million in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -1.30 Mn |
| Dec 31, 2015 | -73,000.00 |